Company news
Profound Medical Corp (TSX:PRN) news
Every Profound Medical Corp press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 1, 2026
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
August 17, 2026
Profound Medical Announces Management Change
August 14, 2026
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026
Profound Medical Reports Second Quarter 2026 Financial Results
August 6, 2026
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
July 24, 2026
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
July 16, 2026
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
July 15, 2026
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
May 15, 2026
Profound to Showcase TULSA-PRO®, the TULSA Procedure(TM) and the Future of iMRI at AUA2026
May 14, 2026
Profound Medical Reports Strong First Quarter 2026 Financial Results
May 7, 2026
Profound Medical to Release First Quarter 2026 Financial Results on May 7 Conference Call to Follow
April 17, 2026
Profound Medical to Release First Quarter 2026 Financial Results on May 7 - Conference Call to Follow
April 16, 2026
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2026
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 202...
April 1, 2026
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure(TM) Milestone
March 27, 2026
Upcoming Meeting Dates - March 23, 2026
March 23, 2026
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoin...
March 13, 2026
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endp...
March 13, 2026
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investo...
March 9, 2026
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow
February 13, 2026
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow
February 12, 2026
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure(TM) for Prostate Disease
February 12, 2026
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
February 5, 2026
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health
February 5, 2026
Profound Medical Announces Upcoming Investor Events
January 27, 2026
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
January 12, 2026
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
January 12, 2026
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 6, 2026
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 6, 2026
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before Decem...
December 23, 2025
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subse...
December 19, 2025
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 4, 2025
Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 4, 2025
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi...
November 11, 2025